EPAS1

From WikiMD's WELLNESSPEDIA

EPAS1 or Endothelial PAS domain-containing protein 1 is a protein that in humans is encoded by the EPAS1 gene. This protein is also commonly known as Hypoxia-inducible factor 2 alpha (HIF-2α). It is a transcription factor involved in the body's response to low oxygen levels, or hypoxia.

Function[edit]

EPAS1 is a member of the PAS domain family of transcription factors. It is involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels.

EPAS1 plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. It also plays a role in the regulation of oxygen homeostasis, and is involved in the adaptive response to hypoxic stress in the heart, lung and other tissues.

Clinical significance[edit]

Mutations in the EPAS1 gene have been associated with Erythrocytosis, a condition characterized by an excessive production of red blood cells. In addition, EPAS1 mutations have been implicated in certain types of cancer, including renal cell carcinoma and glioblastoma multiforme, where they contribute to the growth and survival of tumor cells in low-oxygen environments.

Research[edit]

Research into the role of EPAS1 in disease is ongoing. It is thought that understanding the function of this gene could lead to new treatments for conditions such as cancer and ischemic diseases.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.